How to Penetrate the Brazilian Pharmaceutical Market
Specialty pharmaceutical companies often face higher entry barriers when attempting to enter technology-driven markets. Success in markets such as the US, EU, and Japan has largely been attributed to strategic partnerships. However, when it comes to Brazil, these partnerships need to be approached differently.
Understanding the Brazilian Market
Brazil is the world's fifth largest country, with nearly 85% of its population residing in urban areas. The country's GDP per capita, currently at USD 8,717, is expected to grow as the political landscape evolves. Despite the opportunities, only a few international companies have established a significant presence in Brazil's pharmaceutical sector. This market is largely dominated by local companies that cater to domestic demand.
Challenges for International Companies
Why do foreign pharmaceutical companies struggle to enter the Brazilian market? While regulatory hurdles are a factor, they aren't the only challenge. Some of the key difficulties include:
- Data Availability: Major market research firms often overlook the non-retail segment of Brazil's market, which is influenced by government tenders.
- Unique Portfolio Requirements: What works in the US or EU may not necessarily succeed in Brazil.
- Segmented Market: Brazil's pharmaceutical market is divided into three major segments, each requiring a different approach.
- Complex Regulatory System: Brazil’s regulatory body, ANVISA, requires drug equivalency studies and approved CROs for product registration.
- Regulations on Manufacturing: Strict rules on contract manufacturing prevent many pharmaceutical companies from entering Brazil.
Strategies for Entering the Brazilian Market
To successfully penetrate Brazil's pharmaceutical market, companies must consider a dedicated product portfolio and strategic partnerships. The approach can vary depending on the stage of market entry:
Stage 1: New Entrants
For companies with no prior experience in Brazil, partnering for regulatory, importer, and QC lab activities is crucial. Establishing relationships with the right partners is key to navigating the registration process.
Stage 2: Companies with Some Experience
Companies with some experience in Brazil can benefit from partnerships for marketing authorization (MA) holding. Post-authorization, working with distributors or marketing partners for out-licensing may be the simplest route forward.
Stage 3: Expanding Presence in Brazil
For companies looking to deepen their presence in Brazil, setting up an infrastructure or acquiring a partner with local expertise is essential. Planning for the right portfolio, regulatory framework, and business model in alignment with the local market is crucial.
Conclusion
Brazil's pharmaceutical market presents unique challenges, but with the right strategy, companies can successfully penetrate this growing market. By focusing on dedicated partnerships, regulatory compliance, and tailored product offerings, international pharmaceutical companies can overcome the barriers and establish a foothold in Brazil.
No comments:
Post a Comment